Ozempic rebound refers to the weight gain that occurs after the medication has been stopped
Similar content being viewed by others Introduction Obesity is a chronic, progressive, relapsing disease that affects over 40% of adults in the US [1] and is associated with increased risk of morbidity, disability, mortality, and reduced quality of life [2,3,4]
Note that semaglutide is very similar to GLP-1 and its mechanism of action is therefore limited to the activation of the receptor for this hormone, while tirzepatide is made up of an amalgam of amino acids found both in the GLP-1 (yellow circles), GIP (blue circles), and in the two hormones (green circles), which gives it a double agonist activity, capable of activating both receptors for these hormones
By taking semaglutide, you activate the GLP-1 receptors in your body for a prolonged period of time, helping to manage your blood sugar, slow down the emptying of your stomach, and reduce your appetite